S J Kent|I M Lewis - JoVE Visualize

Showing results (31-40 of 53) with videos related to

Pageof 6

Sort By:

Journal of Virology|November 2, 2001

Vaccination with attenuated simian immunodeficiency virus by DNA inoculationS J Kent, C J Dale, S Preiss, et al.

Virology|August 16, 2001

Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivoS J Kent, P U Cameron, J C Reece, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997

Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.

Vaccine|March 16, 2000

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaquesS J Kent, A Zhao, C J Dale, et al.

Immunological Reviews|December 3, 1999

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunityA J Ramsay, S J Kent, R A Strugnell, et al.

Journal of Medical Primatology|November 21, 2000

Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gammaC J Dale, A Zhao, S L Jones, et al.

The Journal of Clinical Investigation|January 1, 1995

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrinaS J Kent, L Corey, M B Agy, et al.

AIDS (London, England)|October 1, 1992

Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicityM A Slavin, J F Hoy, K Stewart, et al.

Journal of Virology|November 13, 1998

Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.

Clinical and Experimental Immunology|February 4, 2015

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activationC-C Tang, G Isitman, J Bruneau, et al.

Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:

Pageof 6

Journal of Virology|November 2, 2001

Vaccination with attenuated simian immunodeficiency virus by DNA inoculationS J Kent, C J Dale, S Preiss, et al.

Virology|August 16, 2001

Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivoS J Kent, P U Cameron, J C Reece, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997

Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.

Vaccine|March 16, 2000

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaquesS J Kent, A Zhao, C J Dale, et al.

Immunological Reviews|December 3, 1999

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunityA J Ramsay, S J Kent, R A Strugnell, et al.

Journal of Medical Primatology|November 21, 2000

Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gammaC J Dale, A Zhao, S L Jones, et al.

The Journal of Clinical Investigation|January 1, 1995

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrinaS J Kent, L Corey, M B Agy, et al.

AIDS (London, England)|October 1, 1992

Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicityM A Slavin, J F Hoy, K Stewart, et al.

Journal of Virology|November 13, 1998

Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.

Clinical and Experimental Immunology|February 4, 2015

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activationC-C Tang, G Isitman, J Bruneau, et al.

Pageof 6